NICHOLAS CATAPANO: Open Payments
NPI 1851046981 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 19 payments from 10 companies in 2025. Trend: 2023 $500 · 2024 $590 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $338 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $252 |
| Axsome Therapeutics, Inc. | 3 | $176 |
| E.R. Squibb & Sons, L.L.C. | 1 | $133 |
| Alkermes, Inc. | 4 | $132 |
| Corium, LLC | 1 | $89 |
| Teva Pharmaceuticals USA, Inc. | 1 | $71 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Orexo US, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: INGREZZA, CAPLYTA, COBENFY, ARISTADA, Azstarys, AUSTEDO XR, Auvelity, FANAPT.
Industry payments across IN — which companies pay providers there.
